These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7475278)

  • 21. Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.
    Gandhi V; Kemena A; Keating MJ; Plunkett W
    Cancer Res; 1992 Feb; 52(4):897-903. PubMed ID: 1737352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
    Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M
    Blood; 1994 Nov; 84(10):3440-6. PubMed ID: 7949099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
    Johnston JB; Kabore AF; Strutinsky J; Hu X; Paul JT; Kropp DM; Kuschak B; Begleiter A; Gibson SB
    Oncogene; 2003 Nov; 22(51):8356-69. PubMed ID: 14614459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
    Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang Y; Albertioni F
    Haematologica; 2003 Mar; 88(3):324-32. PubMed ID: 12651272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells.
    Beck FW; Al-Katib AM; Ahmad I; Wall NR; Liu KZ; Mantsch HH; Mohammad RM
    Int J Mol Med; 2000 Apr; 5(4):341-7. PubMed ID: 10719048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia.
    Koski T; Vilpo L; Vilpo J
    Leuk Res; 1999 Mar; 23(3):277-9. PubMed ID: 10071081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.
    Albertioni F; Lindemalm S; Reichelova V; Pettersson B; Eriksson S; Juliusson G; Liliemark J
    Clin Cancer Res; 1998 Mar; 4(3):653-8. PubMed ID: 9533533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a place for 2-CDA in the treatment of B-CLL?
    Mitterbauer M; Hilgenfeld E; Wilfing A; Jäger U; Knauf WU
    Leukemia; 1997 Apr; 11 Suppl 2():S35-7. PubMed ID: 9178836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
    Duechler M; Linke A; Cebula B; Shehata M; Schwarzmeier JD; Robak T; Smolewski P
    Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
    Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
    King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
    Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistance.
    Juliusson G; Liliemark J
    Leuk Lymphoma; 1994 Mar; 13(1-2):75-80. PubMed ID: 8025525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 39. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
    Krykowski E; Warzocha K; Robak T
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.
    Kost SE; Bouchard ED; LaBossière É; Ye X; Queau ML; Liang WS; Banerji V; Gibson SB; Katyal S; Johnston JB
    Leuk Res; 2016 Nov; 50():63-71. PubMed ID: 27683974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.